Trial
NCT01568216
20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Amgen
Collaborators
—
Condition
Schizophrenia
Intervention
AMG 747
Why stopped
Toxic Epidermal Necrolysis
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-07-30